% Expired Patents = 12.5

Trademarks = 1

Forward Citations = 300

Loading Chart...

5 inventors (with patents filed for the assignee):

Paul A Averback (8 out of 41 patents)

Jack Gemmell (5 out of 11 patents)

Judith Fitzpatrick (1 out of 17 patents)

4. Maggie Focht (1 out of 1 patent)

5. Riza Bibiano (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 8067378 - Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells (2011-11-29),

2. 7408021 - Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells (2008-08-05),

3. 7317077 - Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells (2008-01-08),

4. 7259232 - Preferred segments of neural thread protein (2007-08-21),

5. 7241738 - Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells (2007-07-10),

6. 6461608 - Bacteriophage composition useful in treating food products to prevent bacterial contamination (2002-10-08),

7. 6309892 - Antibodies to components of dense microspheres and methods of using the same (2001-10-30),

8. 5955285 - Method of identifying individuals at risk of suffering from cerebral (1999-09-21),

Company Overview

Nymox Pharmaceutical Corporation is a biopharmaceutical company focused on the research and development of novel therapeutics for a variety of medical conditions. The company's lead product is Fexapotide Triflutate, a treatment for enlarged prostate, which is currently in late-stage clinical trials. Nymox is also exploring other potential therapeutic applications for their proprietary technology. With a commitment to innovation and improving patient outcomes, Nymox is dedicated to bringing new and effective treatments to market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#196 in

#1,878 in Canada

CA

Nymox Pharmaceutical Corporation

Forward Citations = 300

5 inventors:

Paul A Averback (8 out of 41 patents)

Jack Gemmell (5 out of 11 patents)

Judith Fitzpatrick (1 out of 17 patents)

4. Maggie Focht (1 out of 1 patent)

5. Riza Bibiano (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nymox Pharmaceutical Corporation. Retrieved from https://idiyas.com/company/nymox-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]